Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acetylglutamate, acid, adrenalcortical, allergic, approaching, baseline, brand, Carbaglu, carglumic, channel, children, deficiency, earned, endocrinology, epilepsy, Eprontia, formulation, fourth, hyperammonemia, ketotifen, leverage, migraine, ophthalmic, plc, provision, suffer, Synthase, Tolmar, underwritten, version, writing, Xellia
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view